We are live on ! Find out more
Name Net reduced
positions
Reduced positions Increased positions Return since
30 Jun ‘25
SCHJ icon
726
Schwab 1-5 Year Corporate Bond ETF
SCHJ
$868M
1 40 39 2.86%
XFOR icon
727
X4 Pharmaceuticals
XFOR
$288M
1 17 16 52.6%
OBIL icon
728
US Treasury 12 Month Bill ETF
OBIL
$325M
1 22 21 0.8%
PRIV
729
State Street IG Public & Private Credit ETF
PRIV
$798M
1 4 3 4.53%
FLCG
730
Federated Hermes MDT Large Cap Growth ETF
FLCG
$641M
1 4 3 17.9%
ORBS
731
Eightco Holdings
ORBS
$503M
1 4 3 5.65%
DMRA
732
Damora Therapeutics
DMRA
$1.31B
1 4 3 524%
NBBK icon
733
NB Bancorp
NBBK
$969M
1 45 44 23.9%
NATH icon
734
Nathan's Famous
NATH
$416M
1 36 35 8.27%
PTMC icon
735
Pacer Trendpilot US Mid Cap ETF
PTMC
$370M
1 26 25 12.1%
NVDX icon
736
T-Rex 2X Long NVIDIA Daily Target ETF
NVDX
$488M
1 9 8 41.8%
RWK icon
737
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.26B
1 44 43 18.4%
RCBC
738
River City Bank
RCBC
$717M
1 1 0 –
NPK icon
739
National Presto Industries
NPK
$1.06B
1 55 54 51.2%
REI icon
740
Ring Energy
REI
$341M
1 39 38 65%
EMO
741
ClearBridge Energy Midstream Opportunity Fund
EMO
$1B
1 28 27 4.48%
VFVA icon
742
Vanguard US Value Factor ETF
VFVA
$894M
1 30 29 27.4%
BYLD icon
743
iShares Yield Optimized Bond ETF
BYLD
$433M
1 22 21 4.73%
ASMB icon
744
Assembly Biosciences
ASMB
$478M
1 8 7 29.6%
ASLE icon
745
AerSale
ASLE
$250M
1 44 43 12.8%
NUTX
746
Nutex Health
NUTX
$1.45B
1 18 17 70%
ETO
747
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$497M
1 22 21 11.5%
STRO icon
748
Sutro Biopharma
STRO
$267M
1 23 22 126%
PCYO icon
749
Pure Cycle
PCYO
$266M
1 34 33 2.99%
ROMA icon
750
Roma Green Finance Ltd
ROMA
$512M
1 1 0 186%